Palbociclib 75mg: Clinical Trials

1 trial of Palbociclib 75mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Palbociclib 75mg: new trials by email Literature Review of Palbociclib 75mg trials Research Report on Palbociclib 75mg

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Palbociclib 75mg, Letrozole 2.5mg, T-DM1 - HER2-positive Breast Cancer, Breast Cancer Metastatic
Phase 1 / Phase 2TerminatedUniversity of Kansas Medical Center32018-10-152024-03-05

Sponsors

University of Kansas Medical Center (1)

Countries

United States (1)

Top investigators

Lauren Nye, MD (1)